Request PowerPoint
PowerPoint animations are preserved in the original file.
Slide index (76)
- Loading slide titles…
Loading presentation…
Slide text will appear here when the presentation loads.
Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.
Lecture topics
- Outdoor air pollution is a mixed exposure
- Host factors change vulnerability
- Healthy individuals may develop acute effects
- Acid aerosols disrupt airway defense
- Fine particles may promote lung carcinogenesis
- Severity correlates with carboxyhemoglobin burden
- Susceptibility patterns Table 9.1
- Primary textbook and source limitations
Slide index & full transcript (76 slides)
Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.
Slide 1 · Outdoor Air Pollution
Environmental pathology and clinicopathologic mechanisms
Ambient pollutants • mechanisms of injury • clinicopathologic consequences
Dr Abu Suraih Sakhri
MBBS, MD (Pathology)
www.abusuraihsakhri.com
Slide 2 · Learning objectives
Classify major regulated ambient air pollutants and identify important sources.
Explain how oxidant gases and particles injure the respiratory tract and affect systemic health.
Recognize clinical vulnerability patterns and the mechanisms, manifestations, and morphology of carbon monoxide poisoning.
Slide 3 · Outdoor air pollution is a mixed exposure
Ambient air contains gaseous agents and particulate matter rather than a single toxic chemical.
Pollutant mixtures are especially prominent in cities and near heavy industry.
Simultaneous exposure complicates assignment of an individual symptom to one pollutant.
Slide 4 · Why lungs are the primary target
The respiratory tract is directly exposed to ambient gaseous and particulate contaminants.
Epithelial injury and inflammation explain much of the immediate pulmonary disease burden.
Inhaled pollutant
Airway / alveolar contact
Local injury
Mechanistic schematic
Slide 5 · Effects extend beyond the lungs
Adverse effects in multiple organs, possibly mediated by systemic inflammation.
Particulate exposure is particularly associated with secondary cardiovascular effects.
Pulmonary exposure
Inflammatory response
Systemic consequences
Mechanistic schematic
Slide 6 · Exposure is geographically uneven
Major urban centers experience combinations of traffic, industrial, and other combustion emissions.
Concentrations may be especially high near major industrial or transport sources.
Residence, occupation, and time outdoors modify the circumstances of exposure.
Slide 7 · A useful first classification
Gaseous pollutants
Ozone (O₃), nitrogen dioxide (NO₂), sulfur dioxide (SO₂)
Carbon monoxide (CO): Systemic asphyxiant
Different gases produce different tissue-level effects
Particulate pollutants
Solid or liquid material suspended in air
Categorized by aerodynamic size (PM₁₀; PM₂.₅)
Fine particles can reach distal airspaces
Slide 8 · Six pollutants covered by ambient standards
Pollutant
Symbol / category
Core clinical emphasis
Sulfur dioxide
SO₂
Respiratory irritation and asthma
Carbon monoxide
CO
Carboxyhemoglobin; systemic hypoxia
Ground-level ozone
O₃
Oxidative epithelial injury
Nitrogen dioxide
NO₂
Airway reactivity; infection risk
Lead
Pb
Regulated ambient pollutant; detailed toxicity elsewhere
Particulate matter
PM₁₀ / PM₂.₅
Lung inflammation; cardiac effects
Slide 9 · Particulate size is part of the definition
PM₁₀ designates particles smaller than 10 µm in diameter.
PM₂.₅ designates fine particles smaller than 2.5 µm in diameter.
These are particle-size categories, not specific chemical compositions.
Slide 10 · Smog reflects mixed atmospheric contaminants
The term combines smoke and fog and describes a visibly polluted urban atmosphere.
Ozone may coexist with sulfur dioxide and particles, generating overlapping exposures.
Combustion / industry
Gases + particulates
Urban smog
Mechanistic schematic
Slide 11 · Air pollution long predates modern industry
Early concerns about coal smoke and respiratory disease in London.
John Evelyn described health consequences of thick, contaminated air in 1661.
The distinguishing modern features are pollutant sources, composition, and emission controls.
Slide 12 · Ambient standards are population-level controls
In the United States, the EPA regulates six criteria pollutants through National Ambient Air Quality Standards.
Standards are intended to limit harmful environmental exposures.
They do not guarantee equal biological susceptibility among exposed people.
Slide 13 · Host factors change vulnerability
More vulnerable
Preexisting asthma or chronic obstructive lung disease
Established cardiac or chronic pulmonary disease
Children and persons exercising outdoors (pollutant dependent)
Physiologic considerations
Baseline reserve affects clinical response
Airway reactivity can amplify irritant effects
Exposure duration and intensity matter
Slide 14 · Inhaled xenobiotics can act locally or systemically
The toxicology parent section distinguishes injury at the entry site from injury after systemic transport.
Outdoor pollutants exemplify both patterns: Airway irritants versus CO-mediated tissue hypoxia.
Inhalation
Lung contact / uptake
Local or distant effects
Mechanistic schematic
Slide 15 · Ozone has opposite roles by altitude
Stratospheric ozone
Situated high above the earth
Absorbs harmful solar ultraviolet radiation
Depletion increases environmental vulnerability
Ground-level ozone
Formed in sunlight from emitted precursors
Reactive ambient respiratory pollutant
Can provoke oxidant injury and inflammation
Slide 16 · Altitude determines ozone’s role
Protective ozone in the stratosphere and harmful ozone near the ground are chemically the same molecule.
Health impact depends on atmospheric location and exposure route.
STRATOSPHERE • O₃ absorbs ultraviolet radiation
LOWER ATMOSPHERE • O₃ injures airway epithelium
Slide 17 · Stratospheric ozone intercepts ultraviolet radiation
The stratospheric layer provides a protective atmospheric function.
Robbins locates it roughly 10–30 miles above the earth’s surface.
Solar UV
Ozone layer absorbs UV
Reduced harmful UV at surface
Mechanistic schematic
Slide 18 · Chlorofluorocarbons cause ozone depletion
Chlorofluorocarbons historically used in cooling systems and aerosols can reach the stratosphere.
Chemical reactions involving these compounds destroy ozone molecules.
Released CFC gases
Stratospheric reactions
Ozone destruction
Mechanistic schematic
Slide 19 · The ozone hole became a global policy problem
Marked Antarctic ozone depletion was recognized in 1985.
The Montreal Protocol of 1987 established international phase-out commitments for ozone-depleting compounds.
Declining Antarctic ozone-hole size following reduced CFC use.
Slide 20 · Ground-level ozone is a secondary pollutant
Nitrogen oxides and volatile organic compounds react in the presence of sunlight.
The reactants are released by motor vehicles and industrial sources.
Nitrogen oxides + VOCs
Sunlight-driven reaction
Ozone near ground
Mechanistic schematic
Slide 21 · Precursors are not identical to the product
Emitted precursors
Nitrogen oxides (NOₓ)
Volatile organic compounds (VOCs)
Vehicle exhaust and industrial emissions
Secondary product
O₃ is generated by atmospheric reactions
Sunlight enables the relevant chemistry
Ground-level concentration need not track a single source directly
Slide 22 · Ozone toxicity begins with oxidant chemistry
A major component of ozone toxicity to free radical generation.
Oxidant stress injures the respiratory epithelium and initiates inflammatory responses.
O₃ exposure
Reactive oxygen species
Cellular injury
Mechanistic schematic
Slide 23 · Ozone injures multiple respiratory cell sites
Both conducting airway epithelia and type I alveolar cells are described as vulnerable.
Mediator release links direct cell injury to local pulmonary inflammation.
Airway epithelium
Type I alveolar cells
Inflammatory mediator release
Mechanistic schematic
Slide 24 · Healthy individuals may develop acute effects
Upper respiratory tract inflammation follows exposure.
Symptoms include chest discomfort and reduced pulmonary function.
The response may be modest in a healthy individual yet clinically important in reduced-reserve patients.
Slide 25 · Preexisting obstructive disease increases risk
Healthy respiratory system
Acute inflammatory symptoms
Mild reduction in measured lung function
Reduced exercise tolerance is possible
Asthma or chronic obstruction
More consequential airway narrowing / reactivity
Asthma-related hospitalization burden rises
Greater clinical impact from a similar ambient exposure
Slide 26 · Exercise changes the clinical impact of exposure
Athletes and outdoor workers are exposed during sustained outdoor activity.
Ozone exposure in these populations with reduced exercise capacity.
Exposure assessment should include activity and environment, not only diagnosis.
Slide 27 · Ozone contributes to a combined irritant burden
Ozone often accompanies sulfur dioxide and particulate matter in polluted air.
Multiple inhaled agents can produce overlapping irritation, inflammation, and reduced lung function.
Ozone
Other gases + particles
Mixed respiratory insult
Mechanistic schematic
Slide 28 · Nitrogen dioxide affects airway reactivity
NO₂ is one of the six regulated ambient air pollutants.
Robbins’ health-effects table associates exposure with increased airway reactivity in healthy adults.
Its clinical effects are particularly relevant to susceptible respiratory populations.
Slide 29 · NO₂: Different groups, different outcomes
Adults with asthma
Decreased lung function in the source table
Underlying hyperreactive airways increase clinical significance
Children
Increased respiratory infections in the source table
Observed outcome differs from acute physiologic reactivity
Slide 30 · Sulfur dioxide is linked to fuel combustion
Coal- and oil-burning power plants emit sulfur dioxide.
Copper smelting and paper mills are additional sources.
Source recognition is useful for interpreting industrial and urban exposure contexts.
Slide 31 · Atmospheric transformation produces irritant species
Released sulfur dioxide can be converted into sulfur trioxide and sulfuric acid.
These irritant products contribute to burning sensations and respiratory symptoms.
SO₂ emission
Sulfur trioxide / acid formation
Mucosal irritation
Mechanistic schematic
Slide 32 · Upper-airway irritation is a prominent effect
Burning sensations may occur in the nose and throat.
Exposed individuals can experience difficulty breathing.
These symptoms reflect direct irritation of respiratory mucosa.
Slide 33 · Underlying lung disease alters severity
Without established disease
Increased respiratory symptoms
Acute irritation and breathing difficulty
With lung disease / asthma
Asthma attacks and reduced pulmonary function
Increased hospitalizations reported in the source table
Higher vulnerability among chronic lung disease groups
Slide 34 · Acid aerosols disrupt airway defense
The source table associates acid aerosol exposure with altered mucociliary clearance.
Mucociliary transport normally helps remove inhaled material from conducting airways.
Children show increased respiratory infections in the source table.
Slide 35 · Impaired clearance creates a clinical link
Loss of efficient airway clearance provides a mechanistic interpretation for observed infection associations.
The table also identifies lower lung function and hospitalization in people with asthma.
Acid aerosol exposure
Altered mucociliary clearance
Greater susceptibility to infection
Mechanistic schematic
Slide 36 · Particulate matter is heterogeneous
Particulates are commonly called soot discussion.
Different materials share a size-based classification despite variable chemical composition.
The source highlights the pulmonary and cardiovascular morbidity associated with particles.
Slide 37 · Combustion is a major source of particulates
Coal- and oil-fired power plants emit particulates.
Industrial combustion processes add to ambient particulate levels.
Diesel exhaust is another important source.
Slide 38 · Particle diameter influences where material deposits
Larger particles are more often removed in the nose or by mucociliary transport.
Fine particles penetrate deeper and may reach the alveolar compartment.
Coarse fraction
Upper-airway capture
PM₁₀
Thoracic penetration
PM₂.₅
Fine; Reaches alveoli
Slide 39 · Upper-airway capture versus alveolar access
Particles >10 µm
More likely to be filtered by the nose
May become trapped in mucus and cleared by airway cilia
Reduced access to alveolar spaces
Fine particles
Can enter small airways and alveoli
Encounter alveolar inflammatory cells
Provoke distal lung inflammation
Slide 40 · Alveolar phagocytes recognize inhaled particles
Phagocytosis of inhaled particles by macrophages and neutrophils.
These activated cells release inflammatory mediators following uptake.
Fine-particle deposition
Macrophages / neutrophils
Mediator release
Mechanistic schematic
Slide 41 · Inflammation is the central injury pathway
Particle-induced inflammatory signaling can worsen preexisting respiratory disease.
This is central to the morbidity associated with airborne particles.
Particle uptake
Pulmonary inflammation
Clinical exacerbation
Mechanistic schematic
Slide 42 · Children are a vulnerable respiratory group
Robbins’ health-effects table associates particle exposure with increased respiratory infections in children.
Respiratory outcomes vary across age groups and underlying disease status.
The association concerns exposure-related population risk, not a disease-specific histologic pattern.
Slide 43 · Pulmonary and cardiac consequences coexist
Pulmonary
Airway / alveolar inflammation
Decreased lung function in chronic lung disease
Exacerbation of existing pulmonary illness
Cardiovascular
Secondary adverse cardiac effects
Greater concern when baseline heart disease exists
Cardiac exacerbations contribute to mortality burden
Slide 44 · Particle exposure is linked to daily mortality
An association between increased ambient PM₁₀ and overall daily mortality.
Exacerbation of pulmonary and cardiac disease accounts for much of this risk.
The exact numeric estimate in the project Markdown contains an apparent unit-transcription problem and is intentionally not reproduced here.
Slide 45 · Fine particles may promote lung carcinogenesis
Experimental work suggesting inhaled particulates can promote lung cancer.
The statement concerns experimental evidence and should not be represented as a quantified clinical effect.
The source excerpt does not specify a single molecular pathway, histologic subtype, or attributable risk.
Slide 46 · Pulmonary inflammation may affect distant organs
The textbook suggests systemic inflammation as one explanation for effects outside the lung.
This model links the primary inhalational exposure with cardiac complications without assuming direct particle translocation.
Inhaled particulate
Lung inflammation
Secondary cardiovascular effects
Mechanistic schematic
Slide 47 · Interpret particle risk in context
Size predicts deposition pattern, but composition and individual susceptibility remain relevant.
Particulate concentration is a population-level exposure measure rather than a clinical diagnosis.
The same ambient episode may present as respiratory or cardiac deterioration across patients.
Slide 48 · Carbon monoxide is produced by incomplete oxidation
CO forms when carbonaceous fuels are incompletely burned.
Common sources include engines, furnaces, and cigarettes.
Unlike the irritant pollutants, CO primarily threatens oxygen transport and tissue oxygenation.
Slide 49 · CO is difficult to detect without measurement
Physical properties
Colorless
Odorless and tasteless
Nonirritating gas
Clinical implication
Exposure may not be noticed
Symptoms can progress insidiously
The environment and exposure history are essential clues
Slide 50 · Ambient CO elevations tend to be localized
CO is relatively short-lived in outdoor air because it is oxidized to carbon dioxide.
Elevated outdoor concentrations may therefore be transient and close to sources.
Confinement near combustion equipment can produce disproportionately hazardous exposures.
Slide 51 · Occupational contexts can produce chronic exposure
Tunnels, underground garages, and highway toll booths as settings with automobile fumes.
Persistent low-level exposure is relevant even without an acute high-dose event.
Source proximity and repeated exposure help distinguish chronic from single-event poisoning.
Slide 52 · Closed spaces magnify acute CO danger
An enclosed garage containing a running engine can rapidly accumulate dangerous CO.
Improperly used gasoline-powered generators may produce poisoning during power outages.
Mine fires are another setting described for potentially severe exposure.
Slide 53 · CO displaces oxygen from hemoglobin
Hemoglobin has markedly higher affinity for CO than for oxygen—about 200-fold.
Carboxyhemoglobin cannot transport oxygen in the usual manner.
CO inhalation
Carboxyhemoglobin
Reduced O₂ transport
Mechanistic schematic
Slide 54 · Loss of functional hemoglobin causes tissue hypoxia
Tissue injury reflects impaired oxygen transport rather than primary airway inflammation.
High oxygen demand makes the central nervous system especially vulnerable.
Hemoglobin bound by CO
Reduced oxygen delivery
Systemic hypoxia
Mechanistic schematic
Slide 55 · Severity correlates with carboxyhemoglobin burden
Systemic hypoxia when CO occupies roughly 20–30% of hemoglobin.
Unconsciousness and death become likely with approximately 60–70% saturation.
These textbook ranges illustrate severity; Clinical presentation must still be assessed in context.
Slide 56 · Neurologic depression can be deceptively insidious
Progressive central nervous system depression may occur without a marked irritant warning.
Affected individuals may become unable to recognize or escape the exposure.
CO exposure
Progressive tissue hypoxia
CNS depression
Mechanistic schematic
Slide 57 · Chronic CO exposure can accumulate biologic burden
The stability of carboxyhemoglobin after it forms.
Repeated or persistent exposure can produce substantial carboxyhemoglobin levels.
Slowly developing hypoxia may cause widespread ischemic injury in the brain.
Slide 58 · Basal ganglia are notably vulnerable
Chronic CO poisoning can produce CNS ischemic injury.
The textbook particularly identifies the basal ganglia and lenticular nuclei.
Regional vulnerability should be understood as hypoxic injury, not a unique toxic deposit.
Slide 59 · Neurologic sequelae may persist after exposure ends
Many patients improve following removal from exposure.
Permanent deficits may affect memory, vision, hearing, and speech.
Persistent neurologic impairment reflects the consequences of prior tissue injury.
Slide 60 · Acute poisoning may be fatal before lesions evolve
Short, intense CO exposures can induce unconsciousness or death.
When death occurs very rapidly, morphologic changes may be absent.
The absence of gross lesions therefore does not exclude severe CO poisoning.
Slide 61 · Morphology in survivors reflects hypoxia
Possible brain findings
Mild edema
Punctate hemorrhages
Hypoxia-associated neuronal changes
Interpretive limitation
Not specific to CO
Depend on survival time and degree of hypoxia
Require exposure history and blood testing
Slide 62 · Cherry-red discoloration is a limited clue
Cherry-red skin and mucous membranes in light-skinned individuals with acute poisoning.
Coloration may obscure the severity of underlying oxygen deprivation.
It should not be used alone to exclude or establish a diagnosis.
Slide 63 · Confirm exposure by blood measurement
Robbins specifies measurement of blood carboxyhemoglobin for diagnosis.
Clinical interpretation also depends on the exposure history and neurologic findings.
Suspected CO exposure
Blood carboxyhemoglobin
Diagnosis supported
Mechanistic schematic
Slide 64 · Irritant injury differs from systemic asphyxiation
O₃ / SO₂ / particles
Airway epithelium or alveolar interaction
Oxidative and/or inflammatory responses
Respiratory symptoms; Downstream cardiac burden for PM
CO
High-affinity hemoglobin binding
Reduced blood oxygen transport
CNS depression and hypoxic organ injury
Slide 65 · Characteristic associations across pollutants
Agent
Mechanism emphasized
Characteristic clinical effects
Ozone
ROS and epithelial injury
Airway inflammation; ↓ lung function
NO₂
Airway reactivity
Asthmatic ↓ function; infections in children
SO₂ / acid aerosols
Respiratory mucosal irritation
Asthma attacks; altered clearance
Particulates
Phagocyte activation, inflammation
Pulmonary + secondary cardiac disease
CO
Carboxyhemoglobin / systemic hypoxia
Neurologic depression; ischemic injury
Slide 66 · Susceptibility patterns Table 9.1
Population
Pollutant concern
Associated effect
Healthy adults
O₃ / NO₂
Airway reactivity or lower lung function
Asthma
O₃ / SO₂ / acid aerosols
Reduced function; hospitalization
Children
NO₂ / acid aerosols / PM
Respiratory infections
Chronic pulmonary or cardiac disease
PM; SO₂ in chronic lung disease
Exacerbation and mortality burden
Athletes and outdoor workers
O₃
Reduced exercise capacity
Slide 67 · Case: Episodic wheeze during urban smog
CLINICAL PRESENTATION
A patient with established asthma develops chest tightness and worsening breathlessness after prolonged outdoor activity on a heavily polluted afternoon.
QUESTION
Which pollutant-related mechanisms most directly explain the deterioration?
Slide 68 · Interpretation: Oxidant and irritant exposure
Ground-level ozone can produce reactive oxygen species, epithelial injury, and inflammatory mediator release.
Sulfur dioxide and acidic derivatives may add airway irritation and trigger asthma attacks.
The mixed nature of smog prevents attributing the episode to one pollutant without exposure data.
Slide 69 · Case: Coma beside combustion equipment
CLINICAL PRESENTATION
A person is found unconscious in an enclosed space containing a running fuel-powered device. There is no obvious smell or irritant warning.
QUESTION
What exposure should be suspected, what is the mechanism, and which blood test supports the diagnosis?
Slide 70 · Interpretation: Carbon monoxide poisoning
Suspect CO produced by incomplete oxidation of fuel in the enclosed environment.
CO forms carboxyhemoglobin and impairs systemic oxygen transport, producing CNS hypoxia.
Blood carboxyhemoglobin measurement supports the diagnosis; Characteristic skin color is not required.
Slide 71 · Case: Cardiac deterioration during particulate smog
CLINICAL PRESENTATION
A patient with chronic heart disease develops worsening cardiopulmonary symptoms during a sustained episode of particulate-rich urban pollution.
QUESTION
Which particulate mechanism could link a respiratory exposure to an adverse cardiac effect?
Slide 72 · Interpretation: A lung-to-systemic inflammatory link
Fine particles may reach alveoli and be taken up by macrophages and neutrophils.
Release of inflammatory mediators explains pulmonary inflammation and suggests a pathway to systemic effects.
The textbook links particulate exposure with exacerbations of preexisting pulmonary and cardiac disease.
Slide 73 · The major mechanism map
For ozone and particulates, epithelial oxidant injury or inflammatory-cell activation dominates.
For carbon monoxide, impaired hemoglobin-mediated oxygen delivery dominates.
Ambient exposure
Local injury / Hb binding
Pulmonary or systemic illness
Mechanistic schematic
Slide 74 · Population protection and individual care address different levels
Ambient emission control targets exposure in whole populations.
Clinical risk assessment identifies asthma, chronic lung disease, cardiac disease, activity patterns, and combustion environments.
A suspected CO exposure requires prompt recognition because it may occur without odor or airway irritation.
Slide 75 · Core clinicopathologic conclusions
Ambient air pollution is a mixture: Gas chemistry and particle size determine exposure biology.
Oxidant gases injure epithelium; Fine particles recruit inflammatory cells and have systemic associations.
CO is mechanistically different: Carboxyhemoglobin produces hypoxia and often neurologic injury.
Preexisting pulmonary or cardiac disease changes the consequences of exposure.
Slide 76 · Primary textbook and source limitations
Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th edition (2026), Chapter 9, printed pp. 371–373.
Table 9.1 (Health Effects of Outdoor Air Pollutants) cites Bascom R et al. Am J Respir Crit Care Med. 1996;153:477–498.
Content derived from supplied project Markdown; original chapter PDF and source figures were not supplied for visual cross-checking.